{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:50:06Z","timestamp":1778071806311,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiometabolic index (CMI), visceral adiposity index (VAI), and lipid accumulation product (LAP) are lipid-related parameters that reflect central obesity, which is closely associated with the development of non-alcoholic fatty liver disease (NAFLD). The aim of this study is to investigate the effectiveness of these lipid-related parameters in diagnosing NAFLD and to compare their predictive abilities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This population-based study extracted datasets from the National Health and Nutrition Examination Survey (NHANES) 2017\u20132020. CMI, VAI, and LAP were included in the multivariate logistic model as both continuous and categorical variables to assess the relationship between different lipid-related parameters and NAFLD. To further elucidate this connection, we utilized restricted cubic splines and conducted subgroup analysis. Additionally, the receiver operating characteristics (ROC) curve was employed to evaluate the predictive effectiveness of CMI, VAI, and LAP for NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 2,878 adults as the study population, of whom 1,263 participants were diagnosed with NAFLD. When lipid-related parameters were analyzed as continuous variables, they showed a positive correlation with NAFLD. The OR(95%CI) were 2.29(1.81,2.89) for CMI (per 1-unit), 1.40(1.28,1.52) for VAI (per 1-unit) and 1.15(1.11,1.20) for LAP (per 10-units). This correlation remains statistically significant when the lipid-related parameters are analyzed as categorical variables. In descending order of diagnostic capability for NAFLD, the AUC values are as follows: LAP (0.794), CMI (0.752), and VAI (0.719).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CMI, VAI, and LAP may be important clinical indicators for identifying NAFLD, with LAP demonstrating the best predictive ability among them.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1468228","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:10:15Z","timestamp":1737090615000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipid metabolism indicators provide tools for the diagnosis of non-alcoholic fatty liver disease: results of a nationwide survey"],"prefix":"10.3389","volume":"15","author":[{"given":"Yongxin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol Commun"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2744","article-title":"Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration","volume":"18","author":"Sun","year":"2012","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1790-5","article-title":"Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease","volume":"41","author":"Eguchi","year":"2006","journal-title":"J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00535-007-2107-z","article-title":"The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies","volume":"42","author":"Koda","year":"2007","journal-title":"J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/liv.v42.11","article-title":"Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals","volume":"42","author":"Saponaro","year":"2022","journal-title":"Liver Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000464","article-title":"Dyslipidemia in nonalcoholic fatty liver disease","volume":"26","author":"Amor","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.2018.38.issue-12","article-title":"Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up","volume":"38","author":"Xu","year":"2018","journal-title":"Liver Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.04.002","article-title":"The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study","volume":"44","author":"Okamura","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.08.042","article-title":"The \u201ccardiometabolic index\u201d as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus","volume":"438","author":"Wakabayashi","year":"2015","journal-title":"Clin Chim Acta"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4143-x","article-title":"Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12876-022-02099-y","article-title":"Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population","volume":"22","author":"Zou","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"831960","DOI":"10.3389\/fendo.2022.831960","article-title":"Associations between abdominal obesity indices and nonalcoholic fatty liver disease: chinese visceral adiposity index","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3390\/biomedicines9121890","article-title":"The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis-systematic review and meta-analysis","volume":"9","author":"Ismaiel","year":"2021","journal-title":"Biomedicines."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e058517","DOI":"10.1136\/bmjopen-2021-058517","article-title":"Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003-2018): cross-sectional study","volume":"12","author":"Li","year":"2022","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12944-021-01617-3","article-title":"Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults","volume":"21","author":"Liu","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1038\/s41598-024-64034-3","article-title":"Association between the cardiometabolic index and NAFLD and fibrosis","volume":"14","author":"Yan","year":"2024","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21047","article-title":"Splanchnic lipolysis in human obesity","volume":"113","author":"Nielsen","year":"2004","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i28.9330","article-title":"Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations","volume":"20","author":"Mili\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of Fatty liver","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2010.01.016","article-title":"From the metabolic syndrome to NAFLD or vice versa","volume":"42","author":"Vanni","year":"2010","journal-title":"Dig Liver Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J Clin Invest."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"172715","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2391","article-title":"Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes","volume":"9","author":"Guilherme","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes."},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.165100","article-title":"T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance","volume":"28","author":"Kintscher","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"Sutti","year":"2014","journal-title":"Hepatology."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1365","article-title":"Vibration-controlled transient elastography in NAFLD: review study","volume":"12","author":"Ozercan","year":"2022","journal-title":"Euroasian J Hepatogastroenterol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1468228\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:10:18Z","timestamp":1737090618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1468228\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":41,"alternative-id":["10.3389\/fendo.2024.1468228"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1468228","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"article-number":"1468228"}}